Medicines for Europe

Press Releases of this organisation

TITLE ORGANISATION DATE TOPIC
Driving local excellence, delivering European results Medicines for Europe 06 Nov 2018 Health & Consumers
US interference unacceptable in EU legislative proposal for an SPC manufacturing waiver Medicines for Europe 22 Oct 2018 Health & Consumers
Risk that European Council will “neuter” SPC manufacturing waiver and give foreign (non-EU) manufacturers strong advantage over EU-based manufacturers Medicines for Europe 12 Oct 2018 Health & Consumers
CJEU decision on Gilead’s SPC on Truvada® leads to successful clarification in English court Medicines for Europe 20 Sep 2018 Health & Consumers
SPC manufacturing waiver moves a step closer as influential European Parliament ENVI Committee supports reform Medicines for Europe 18 Sep 2018 Health & Consumers
European Organisation for Specialised Nurses (ESNO) launches switch management guide between similar biological medicines - a guide for nurses Medicines for Europe 26 Jun 2018 Health & Consumers
Medicines for Europe members publish disclosure of Transfers of Value to the healthcare community Medicines for Europe 22 Jun 2018 Health & Consumers
Access, sustainability and manufacturing competitiveness highlighted at global generic, biosimilar and value added pharmaceutical conference in Budapest Medicines for Europe 14 Jun 2018 Health & Consumers
Comprehensive SPC manufacturing waiver key for patient access to medicines, jobs and growth in Europe Medicines for Europe 28 May 2018 Health & Consumers, Social Europe & Jobs
EU Semester Country Specific Recommendations: Improve patient access to medicine and ensure healthcare sustainability Medicines for Europe 24 May 2018 Health & Consumers
Biosimilar Medicines: essential for sustainable access to medicines Medicines for Europe 27 Apr 2018 Health & Consumers
SPC manufacturing waiver, Competition policy, Brexit, pharma incentives European Patent Office take centre stage at 14th Legal Affairs Conference Medicines for Europe 25 Apr 2018 Health & Consumers
Supply chain commitment to tackling problem of medicine shortages Medicines for Europe 02 Mar 2018 Health & Consumers
IGBA launches a Biosimilar Medicines Information Campaign Medicines for Europe 01 Feb 2018 Health & Consumers
IGBA congratulates the Australian Government for maintaining their Biologics Naming Convention and for strengthening pharmacovigilance Medicines for Europe 29 Jan 2018 Health & Consumers
2018 – A year of unprecedented challenges and opportunities for pharmaceutical regulatory systems Medicines for Europe 25 Jan 2018 Health & Consumers
Vigilance saves lives! More focus needed on sustainability and patient engagement Medicines for Europe 24 Jan 2018 Health & Consumers
Report shows life sciences industry alliance is taking action to curb antimicrobial resistance, with more to come Medicines for Europe 18 Jan 2018 Health & Consumers, InfoSociety
Brexit - Life Science Industry Joint Position Paper Medicines for Europe 14 Dec 2017 Health & Consumers, UK in Europe
European Commission launches: “What I need to know about Biosimilar Medicines - Information for patients”, in 23 EU languages Medicines for Europe 29 Nov 2017 Health & Consumers
Europe’s life science industry urges the UK and EU27 to safeguard patients’ access to medicines with a clear transition period and a future cooperation agreement after Brexit Medicines for Europe 28 Nov 2017 Health & Consumers, UK in Europe
Medicines for Europe calls for greater cooperation on value added medicines to improve patient-centric innovation Medicines for Europe 22 Nov 2017 Health & Consumers
Commission sponsored study shows Supplementary Protection Certificate (SPC) Manufacturing Waiver will create Jobs, strengthen the pharmaceutical sector and reduce medicine costs Medicines for Europe 18 Oct 2017 Health & Consumers
Medicines for Europe announces new President, launches Access to Medicines campaign Medicines for Europe 10 Oct 2017 Health & Consumers
Medicines for Europe to join the ISPOR Issue Panel on value added medicines Medicines for Europe 05 Oct 2017 Health & Consumers
Addressing medicine shortages in Europe: Competition is crucial for patient access Medicines for Europe 29 Sep 2017 Health & Consumers, Competition
2017 Biosimilar Medicines Policy Overview: better access is crucial; tailored solutions essential for EU governments Medicines for Europe 12 Sep 2017 Health & Consumers
Oncology, the new era for biosimilar medicines Medicines for Europe 08 Sep 2017 Health & Consumers
Value Added Medicines: Time to adjust the HTA Decision Frameworks for more patient-centric innovation Medicines for Europe 05 Sep 2017 Health & Consumers
Latest Data Shows the Need to Promote Biosimilar and Value Added Medicines for Better Health Medicines for Europe 16 Jun 2017 Health & Consumers

Pages